Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
VirS is a bacterial transcriptional regulator of the AraC/XylS family found in Mycobacterium tuberculosis. It plays a critical role in the bacterium’s ability to sense and respond to environmental stresses, particularly acidic conditions encountered within host macrophages. VirS regulates genes involved in metabolic enzyme production, cell-wall envelope remodeling, efflux pumps, ion transporters, detoxification enzymes, and other transcriptional regulators expressed under low-pH stress. It is essential for the persistence of M. tuberculosis inside host cells and contributes significantly to its virulence. VirS has been proposed as an anti-mycobacterial drug target, and small molecule inhibitors that block its DNA-binding activity have been identified.
Inhibition of VirS DNA-binding activity
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bacterial Transcriptional Regulator VirS (VirS).